Report cover image

Global Decongestant Market Outlook and Growth Opportunities 2025

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 197 Pages
SKU # APRC20360252

Description

Summary

According to APO Research, the global Decongestant market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for Decongestant is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Asia-Pacific market for Decongestant is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the Decongestant market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Europe market for Decongestant is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the Decongestant market include Teva Pharmaceutical Industries Ltd., Novartis AG, Mylan N.V., Ranbaxy Laboratories Ltd., Cipla Ltd. and Beximco Pharmaceuticals Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Decongestant, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Decongestant, also provides the sales of main regions and countries. Of the upcoming market potential for Decongestant, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Decongestant sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Decongestant market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Decongestant sales, projected growth trends, production technology, application and end-user industry.

Decongestant Segment by Company

Teva Pharmaceutical Industries Ltd.
Novartis AG
Mylan N.V.
Ranbaxy Laboratories Ltd.
Cipla Ltd.
Beximco Pharmaceuticals Ltd.
Decongestant Segment by Type

Nasal Sprays
Capsules
Tablets
Decongestant Segment by Application

Research & Academic Laboratories
Hospitals
Clinic
Other
Decongestant Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global Decongestant status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Decongestant market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Decongestant significant trends, drivers, influence factors in global and regions.
6. To analyze Decongestant competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Decongestant market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Decongestant and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Decongestant.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Decongestant market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Decongestant industry.
Chapter 3: Detailed analysis of Decongestant manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Decongestant in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Decongestant in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.

Table of Contents

197 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Decongestant Sales Value (2020-2031)
1.2.2 Global Decongestant Sales Volume (2020-2031)
1.2.3 Global Decongestant Sales Average Price (2020-2031)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Decongestant Market Dynamics
2.1 Decongestant Industry Trends
2.2 Decongestant Industry Drivers
2.3 Decongestant Industry Opportunities and Challenges
2.4 Decongestant Industry Restraints
3 Decongestant Market by Company
3.1 Global Decongestant Company Revenue Ranking in 2024
3.2 Global Decongestant Revenue by Company (2020-2025)
3.3 Global Decongestant Sales Volume by Company (2020-2025)
3.4 Global Decongestant Average Price by Company (2020-2025)
3.5 Global Decongestant Company Ranking (2023-2025)
3.6 Global Decongestant Company Manufacturing Base and Headquarters
3.7 Global Decongestant Company Product Type and Application
3.8 Global Decongestant Company Establishment Date
3.9 Market Competitive Analysis
3.9.1 Global Decongestant Market Concentration Ratio (CR5 and HHI)
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.9.3 2024 Decongestant Tier 1, Tier 2, and Tier 3 Companies
3.10 Mergers and Acquisitions Expansion
4 Decongestant Market by Type
4.1 Decongestant Type Introduction
4.1.1 Nasal Sprays
4.1.2 Capsules
4.1.3 Tablets
4.2 Global Decongestant Sales Volume by Type
4.2.1 Global Decongestant Sales Volume by Type (2020 VS 2024 VS 2031)
4.2.2 Global Decongestant Sales Volume by Type (2020-2031)
4.2.3 Global Decongestant Sales Volume Share by Type (2020-2031)
4.3 Global Decongestant Sales Value by Type
4.3.1 Global Decongestant Sales Value by Type (2020 VS 2024 VS 2031)
4.3.2 Global Decongestant Sales Value by Type (2020-2031)
4.3.3 Global Decongestant Sales Value Share by Type (2020-2031)
5 Decongestant Market by Application
5.1 Decongestant Application Introduction
5.1.1 Research & Academic Laboratories
5.1.2 Hospitals
5.1.3 Clinic
5.1.4 Other
5.2 Global Decongestant Sales Volume by Application
5.2.1 Global Decongestant Sales Volume by Application (2020 VS 2024 VS 2031)
5.2.2 Global Decongestant Sales Volume by Application (2020-2031)
5.2.3 Global Decongestant Sales Volume Share by Application (2020-2031)
5.3 Global Decongestant Sales Value by Application
5.3.1 Global Decongestant Sales Value by Application (2020 VS 2024 VS 2031)
5.3.2 Global Decongestant Sales Value by Application (2020-2031)
5.3.3 Global Decongestant Sales Value Share by Application (2020-2031)
6 Decongestant Regional Sales and Value Analysis
6.1 Global Decongestant Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Decongestant Sales by Region (2020-2031)
6.2.1 Global Decongestant Sales by Region: 2020-2025
6.2.2 Global Decongestant Sales by Region (2026-2031)
6.3 Global Decongestant Sales Value by Region: 2020 VS 2024 VS 2031
6.4 Global Decongestant Sales Value by Region (2020-2031)
6.4.1 Global Decongestant Sales Value by Region: 2020-2025
6.4.2 Global Decongestant Sales Value by Region (2026-2031)
6.5 Global Decongestant Market Price Analysis by Region (2020-2025)
6.6 North America
6.6.1 North America Decongestant Sales Value (2020-2031)
6.6.2 North America Decongestant Sales Value Share by Country, 2024 VS 2031
6.7 Europe
6.7.1 Europe Decongestant Sales Value (2020-2031)
6.7.2 Europe Decongestant Sales Value Share by Country, 2024 VS 2031
6.8 Asia-Pacific
6.8.1 Asia-Pacific Decongestant Sales Value (2020-2031)
6.8.2 Asia-Pacific Decongestant Sales Value Share by Country, 2024 VS 2031
6.9 South America
6.9.1 South America Decongestant Sales Value (2020-2031)
6.9.2 South America Decongestant Sales Value Share by Country, 2024 VS 2031
6.10 Middle East & Africa
6.10.1 Middle East & Africa Decongestant Sales Value (2020-2031)
6.10.2 Middle East & Africa Decongestant Sales Value Share by Country, 2024 VS 2031
7 Decongestant Country-level Sales and Value Analysis
7.1 Global Decongestant Sales by Country: 2020 VS 2024 VS 2031
7.2 Global Decongestant Sales Value by Country: 2020 VS 2024 VS 2031
7.3 Global Decongestant Sales by Country (2020-2031)
7.3.1 Global Decongestant Sales by Country (2020-2025)
7.3.2 Global Decongestant Sales by Country (2026-2031)
7.4 Global Decongestant Sales Value by Country (2020-2031)
7.4.1 Global Decongestant Sales Value by Country (2020-2025)
7.4.2 Global Decongestant Sales Value by Country (2026-2031)
7.5 USA
7.5.1 USA Decongestant Sales Value Growth Rate (2020-2031)
7.5.2 USA Decongestant Sales Value Share by Type, 2024 VS 2031
7.5.3 USA Decongestant Sales Value Share by Application, 2024 VS 2031
7.6 Canada
7.6.1 Canada Decongestant Sales Value Growth Rate (2020-2031)
7.6.2 Canada Decongestant Sales Value Share by Type, 2024 VS 2031
7.6.3 Canada Decongestant Sales Value Share by Application, 2024 VS 2031
7.7 Mexico
7.6.1 Mexico Decongestant Sales Value Growth Rate (2020-2031)
7.6.2 Mexico Decongestant Sales Value Share by Type, 2024 VS 2031
7.6.3 Mexico Decongestant Sales Value Share by Application, 2024 VS 2031
7.8 Germany
7.8.1 Germany Decongestant Sales Value Growth Rate (2020-2031)
7.8.2 Germany Decongestant Sales Value Share by Type, 2024 VS 2031
7.8.3 Germany Decongestant Sales Value Share by Application, 2024 VS 2031
7.9 France
7.9.1 France Decongestant Sales Value Growth Rate (2020-2031)
7.9.2 France Decongestant Sales Value Share by Type, 2024 VS 2031
7.9.3 France Decongestant Sales Value Share by Application, 2024 VS 2031
7.10 U.K.
7.10.1 U.K. Decongestant Sales Value Growth Rate (2020-2031)
7.10.2 U.K. Decongestant Sales Value Share by Type, 2024 VS 2031
7.10.3 U.K. Decongestant Sales Value Share by Application, 2024 VS 2031
7.11 Italy
7.11.1 Italy Decongestant Sales Value Growth Rate (2020-2031)
7.11.2 Italy Decongestant Sales Value Share by Type, 2024 VS 2031
7.11.3 Italy Decongestant Sales Value Share by Application, 2024 VS 2031
7.12 Spain
7.12.1 Spain Decongestant Sales Value Growth Rate (2020-2031)
7.12.2 Spain Decongestant Sales Value Share by Type, 2024 VS 2031
7.12.3 Spain Decongestant Sales Value Share by Application, 2024 VS 2031
7.13 Russia
7.13.1 Russia Decongestant Sales Value Growth Rate (2020-2031)
7.13.2 Russia Decongestant Sales Value Share by Type, 2024 VS 2031
7.13.3 Russia Decongestant Sales Value Share by Application, 2024 VS 2031
7.14 Netherlands
7.14.1 Netherlands Decongestant Sales Value Growth Rate (2020-2031)
7.14.2 Netherlands Decongestant Sales Value Share by Type, 2024 VS 2031
7.14.3 Netherlands Decongestant Sales Value Share by Application, 2024 VS 2031
7.15 Nordic Countries
7.15.1 Nordic Countries Decongestant Sales Value Growth Rate (2020-2031)
7.15.2 Nordic Countries Decongestant Sales Value Share by Type, 2024 VS 2031
7.15.3 Nordic Countries Decongestant Sales Value Share by Application, 2024 VS 2031
7.16 China
7.16.1 China Decongestant Sales Value Growth Rate (2020-2031)
7.16.2 China Decongestant Sales Value Share by Type, 2024 VS 2031
7.16.3 China Decongestant Sales Value Share by Application, 2024 VS 2031
7.17 Japan
7.17.1 Japan Decongestant Sales Value Growth Rate (2020-2031)
7.17.2 Japan Decongestant Sales Value Share by Type, 2024 VS 2031
7.17.3 Japan Decongestant Sales Value Share by Application, 2024 VS 2031
7.18 South Korea
7.18.1 South Korea Decongestant Sales Value Growth Rate (2020-2031)
7.18.2 South Korea Decongestant Sales Value Share by Type, 2024 VS 2031
7.18.3 South Korea Decongestant Sales Value Share by Application, 2024 VS 2031
7.19 India
7.19.1 India Decongestant Sales Value Growth Rate (2020-2031)
7.19.2 India Decongestant Sales Value Share by Type, 2024 VS 2031
7.19.3 India Decongestant Sales Value Share by Application, 2024 VS 2031
7.20 Australia
7.20.1 Australia Decongestant Sales Value Growth Rate (2020-2031)
7.20.2 Australia Decongestant Sales Value Share by Type, 2024 VS 2031
7.20.3 Australia Decongestant Sales Value Share by Application, 2024 VS 2031
7.21 Southeast Asia
7.21.1 Southeast Asia Decongestant Sales Value Growth Rate (2020-2031)
7.21.2 Southeast Asia Decongestant Sales Value Share by Type, 2024 VS 2031
7.21.3 Southeast Asia Decongestant Sales Value Share by Application, 2024 VS 2031
7.22 Brazil
7.22.1 Brazil Decongestant Sales Value Growth Rate (2020-2031)
7.22.2 Brazil Decongestant Sales Value Share by Type, 2024 VS 2031
7.22.3 Brazil Decongestant Sales Value Share by Application, 2024 VS 2031
7.23 Argentina
7.23.1 Argentina Decongestant Sales Value Growth Rate (2020-2031)
7.23.2 Argentina Decongestant Sales Value Share by Type, 2024 VS 2031
7.23.3 Argentina Decongestant Sales Value Share by Application, 2024 VS 2031
7.24 Chile
7.24.1 Chile Decongestant Sales Value Growth Rate (2020-2031)
7.24.2 Chile Decongestant Sales Value Share by Type, 2024 VS 2031
7.24.3 Chile Decongestant Sales Value Share by Application, 2024 VS 2031
7.25 Colombia
7.25.1 Colombia Decongestant Sales Value Growth Rate (2020-2031)
7.25.2 Colombia Decongestant Sales Value Share by Type, 2024 VS 2031
7.25.3 Colombia Decongestant Sales Value Share by Application, 2024 VS 2031
7.26 Peru
7.26.1 Peru Decongestant Sales Value Growth Rate (2020-2031)
7.26.2 Peru Decongestant Sales Value Share by Type, 2024 VS 2031
7.26.3 Peru Decongestant Sales Value Share by Application, 2024 VS 2031
7.27 Saudi Arabia
7.27.1 Saudi Arabia Decongestant Sales Value Growth Rate (2020-2031)
7.27.2 Saudi Arabia Decongestant Sales Value Share by Type, 2024 VS 2031
7.27.3 Saudi Arabia Decongestant Sales Value Share by Application, 2024 VS 2031
7.28 Israel
7.28.1 Israel Decongestant Sales Value Growth Rate (2020-2031)
7.28.2 Israel Decongestant Sales Value Share by Type, 2024 VS 2031
7.28.3 Israel Decongestant Sales Value Share by Application, 2024 VS 2031
7.29 UAE
7.29.1 UAE Decongestant Sales Value Growth Rate (2020-2031)
7.29.2 UAE Decongestant Sales Value Share by Type, 2024 VS 2031
7.29.3 UAE Decongestant Sales Value Share by Application, 2024 VS 2031
7.30 Turkey
7.30.1 Turkey Decongestant Sales Value Growth Rate (2020-2031)
7.30.2 Turkey Decongestant Sales Value Share by Type, 2024 VS 2031
7.30.3 Turkey Decongestant Sales Value Share by Application, 2024 VS 2031
7.31 Iran
7.31.1 Iran Decongestant Sales Value Growth Rate (2020-2031)
7.31.2 Iran Decongestant Sales Value Share by Type, 2024 VS 2031
7.31.3 Iran Decongestant Sales Value Share by Application, 2024 VS 2031
7.32 Egypt
7.32.1 Egypt Decongestant Sales Value Growth Rate (2020-2031)
7.32.2 Egypt Decongestant Sales Value Share by Type, 2024 VS 2031
7.32.3 Egypt Decongestant Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 Teva Pharmaceutical Industries Ltd.
8.1.1 Teva Pharmaceutical Industries Ltd. Comapny Information
8.1.2 Teva Pharmaceutical Industries Ltd. Business Overview
8.1.3 Teva Pharmaceutical Industries Ltd. Decongestant Sales, Value and Gross Margin (2020-2025)
8.1.4 Teva Pharmaceutical Industries Ltd. Decongestant Product Portfolio
8.1.5 Teva Pharmaceutical Industries Ltd. Recent Developments
8.2 Novartis AG
8.2.1 Novartis AG Comapny Information
8.2.2 Novartis AG Business Overview
8.2.3 Novartis AG Decongestant Sales, Value and Gross Margin (2020-2025)
8.2.4 Novartis AG Decongestant Product Portfolio
8.2.5 Novartis AG Recent Developments
8.3 Mylan N.V.
8.3.1 Mylan N.V. Comapny Information
8.3.2 Mylan N.V. Business Overview
8.3.3 Mylan N.V. Decongestant Sales, Value and Gross Margin (2020-2025)
8.3.4 Mylan N.V. Decongestant Product Portfolio
8.3.5 Mylan N.V. Recent Developments
8.4 Ranbaxy Laboratories Ltd.
8.4.1 Ranbaxy Laboratories Ltd. Comapny Information
8.4.2 Ranbaxy Laboratories Ltd. Business Overview
8.4.3 Ranbaxy Laboratories Ltd. Decongestant Sales, Value and Gross Margin (2020-2025)
8.4.4 Ranbaxy Laboratories Ltd. Decongestant Product Portfolio
8.4.5 Ranbaxy Laboratories Ltd. Recent Developments
8.5 Cipla Ltd.
8.5.1 Cipla Ltd. Comapny Information
8.5.2 Cipla Ltd. Business Overview
8.5.3 Cipla Ltd. Decongestant Sales, Value and Gross Margin (2020-2025)
8.5.4 Cipla Ltd. Decongestant Product Portfolio
8.5.5 Cipla Ltd. Recent Developments
8.6 Beximco Pharmaceuticals Ltd.
8.6.1 Beximco Pharmaceuticals Ltd. Comapny Information
8.6.2 Beximco Pharmaceuticals Ltd. Business Overview
8.6.3 Beximco Pharmaceuticals Ltd. Decongestant Sales, Value and Gross Margin (2020-2025)
8.6.4 Beximco Pharmaceuticals Ltd. Decongestant Product Portfolio
8.6.5 Beximco Pharmaceuticals Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Decongestant Value Chain Analysis
9.1.1 Decongestant Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Decongestant Sales Mode & Process
9.2 Decongestant Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Decongestant Distributors
9.2.3 Decongestant Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.